Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1949 1
1950 3
1951 3
1952 2
1953 3
1954 4
1955 2
1956 2
1957 2
1959 2
1960 1
1961 3
1962 1
1963 1
1964 3
1965 6
1966 6
1967 1
1969 1
1970 7
1971 2
1972 3
1973 1
1975 4
1976 5
1977 4
1978 4
1979 5
1980 7
1981 3
1982 4
1983 5
1984 6
1985 5
1986 3
1987 6
1988 7
1989 9
1990 5
1991 7
1992 9
1993 8
1994 12
1995 7
1996 4
1997 7
1998 11
1999 8
2000 11
2001 9
2002 6
2003 9
2004 7
2005 17
2006 15
2007 10
2008 3
2009 12
2010 11
2011 9
2012 12
2013 6
2014 12
2015 14
2016 9
2017 11
2018 6
2019 8
2020 20
2021 28
2022 36
2023 26
2024 34
2025 39
2026 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Results by year

Filters applied: . Clear all
Page 1
Insulin resistant diabetes mellitus in SHORT syndrome: case report and literature review.
Masunaga Y, Fujisawa Y, Muramatsu M, Ono H, Inoue T, Fukami M, Kagami M, Saitsu H, Ogata T. Masunaga Y, et al. Endocr J. 2021 Jan 28;68(1):111-117. doi: 10.1507/endocrj.EJ20-0291. Epub 2020 Sep 3. Endocr J. 2021. PMID: 32879144 Free article. Review.
SHORT syndrome is a rare developmental disorder frequently associated with growth failure and insulin resistant diabetes mellitus (IRDM). Since GH has a diabetogenic effect, GH therapy has been regarded as a contraindication. ...
SHORT syndrome is a rare developmental disorder frequently associated with growth failure and insulin resistant diabetes …
Insulin resistance and insulin sensitizing agents.
Mastrototaro L, Roden M. Mastrototaro L, et al. Metabolism. 2021 Dec;125:154892. doi: 10.1016/j.metabol.2021.154892. Epub 2021 Sep 23. Metabolism. 2021. PMID: 34563556 Free article. Review.
Insulin resistance is a common feature of obesity and type 2 diabetes, but novel approaches of diabetes subtyping (clustering) revealed variable degrees of insulin resistance in people with diabetes. Specifically, the severe insulin resistant diabetes (SIRD) …
Insulin resistance is a common feature of obesity and type 2 diabetes, but novel approaches of diabetes subtyping (clustering) revealed vari …
Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes.
Bonnefond A, Semple RK. Bonnefond A, et al. Diabetologia. 2022 Nov;65(11):1782-1795. doi: 10.1007/s00125-022-05720-7. Epub 2022 May 27. Diabetologia. 2022. PMID: 35618782 Free PMC article. Review.
The benign trajectory of diabetes due to pathogenic GCK mutations, and the sulfonylurea-hyperresponsiveness conferred by activating KCNJ11 or ABCC8 mutations, or loss-of-function HNF1A or HNF4A mutations, often decisively guide clinical management. In monogenic insulin- …
The benign trajectory of diabetes due to pathogenic GCK mutations, and the sulfonylurea-hyperresponsiveness conferred by activating KCNJ11 o …
[INSULIN-RESISTANT DIABETES].
HIRATA Y. HIRATA Y. Saishin Igaku. 1964 Aug;19:2120-8. Saishin Igaku. 1964. PMID: 14180316 Review. Japanese. No abstract available.
[Insulin resistant diabetes].
Sakamoto Y, Kuzuya T. Sakamoto Y, et al. Nihon Rinsho. 1981 Sep;39(9):3062-9. Nihon Rinsho. 1981. PMID: 7040738 Review. Japanese. No abstract available.
Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.
Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z, Liu P, Liu Z, Huang H. Xiao H, et al. Acta Pharm Sin B. 2022 Jun;12(6):2887-2904. doi: 10.1016/j.apsb.2021.12.023. Epub 2022 Jan 6. Acta Pharm Sin B. 2022. PMID: 35755276 Free PMC article.
The obstruction of post-insulin receptor signaling is the main mechanism of insulin-resistant diabetes. Progestin and adipoQ receptor 3 (PAQR3), a key regulator of inflammation and metabolism, can negatively regulate the PI3K/AKT signaling pathway. ...
The obstruction of post-insulin receptor signaling is the main mechanism of insulin-resistant diabetes. Progestin and a …
Subtypes of Type 2 Diabetes Determined From Clinical Parameters.
Ahlqvist E, Prasad RB, Groop L. Ahlqvist E, et al. Diabetes. 2020 Oct;69(10):2086-2093. doi: 10.2337/dbi20-0001. Epub 2020 Aug 25. Diabetes. 2020. PMID: 32843567
Importantly, the group with severe insulin-deficient diabetes (SIDD) had increased risk of retinopathy and neuropathy, whereas the severe insulin-resistant diabetes (SIRD) group had the highest risk for diabetic kidney disease (DKD) and fatty liver, emphasizi …
Importantly, the group with severe insulin-deficient diabetes (SIDD) had increased risk of retinopathy and neuropathy, whereas the severe …
Insulin-resistant diabetes mellitus.
Kalkay MN, Bergen SS Jr. Kalkay MN, et al. Postgrad Med. 1970 Mar;47(3):107-11. doi: 10.1080/00325481.1970.11697403. Postgrad Med. 1970. PMID: 5418271 No abstract available.
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.
Pafili K, Roden M. Pafili K, et al. Mol Metab. 2021 Aug;50:101122. doi: 10.1016/j.molmet.2020.101122. Epub 2020 Nov 19. Mol Metab. 2021. PMID: 33220492 Free PMC article. Review.
MAJOR CONCLUSIONS: Recent studies have provided evidence that certain conditions, for example, the severe insulin-resistant diabetes (SIRD) subgroup (cluster) and the presence of an increasing number of gene variants, seem to predispose for excessive risk of …
MAJOR CONCLUSIONS: Recent studies have provided evidence that certain conditions, for example, the severe insulin-resistant …
577 results